Inhibition of DNA repair by Pentoxifylline and related methylxanthine derivatives

Toxicology

Volumn 193, Issue 1-2, 2003, Pages 153-160

  Böhm, Lothar ^a   Roos, Wynand Paul ^a,b   Serafin, Antonio Mendes ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Checkpoint abrogation; DNA repair inhibition; Pentoxifylline; Tumor oxygenation

Indexed keywords

ATM PROTEIN; DNA; METHYLXANTHINE DERIVATIVE; PENTOXIFYLLINE; PROTEIN KINASE; PROTEIN P53; RADIOSENSITIZING AGENT;

CELL CYCLE G2 PHASE; CELL STRAIN; DNA DETERMINATION; DNA SYNTHESIS INHIBITION; DRUG ACTIVITY; DRUG INHIBITION; DRUG MEGADOSE; EXCISION REPAIR; GEL ELECTROPHORESIS; GROWTH REGULATION; HUMAN; MITOSIS INHIBITION; MITOSIS RATE; PRIORITY JOURNAL; PROTEIN FAMILY; RADIATION DOSE FRACTIONATION; REVIEW; TARGET CELL DESTRUCTION; TUMOR GROWTH; ULTRAVIOLET IRRADIATION;

EID: 0242299702     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00294-4     Document Type: Review

References (72)

1. Akimoto T., Mitsuhashi N., Matsumato H., Sakurai H., Maebayashi K., Nozaki M., Niibe H. Potentially lethal damage repair and its inhibiting effect of caffeine in two yolk sac tumour cell lines with different radiosensitivities. Cancer Lett. 147:1999;199-206.
2. Anon, 1996. Merck Index (Susan Budavari). Merck & Co., Whitehouse Station, NJ, USA.
3. Anon, 1999. Therapeutic Drugs (Colling Dollery). Churchill Livingstone, Edinburgh, London, NY, USA.
4. Antignanai P.L., Todini A.R., Saliceli F. Results of clinical, laboratory and haemorheological investigations of the use of Pentoxifylline in high doses. Pharmatherapeutica. 5:1989;50-56.
5. Asaad N.A., Zeng Z., Guan J., Thacker J., Iliakis G. Homologous recombination as a potential target for caffeine radiosensitisation in mammalian cells reduced caffeine radiosensitisation in XRSS2 and XRSCC 3 mutants. Oncogene. 129:2000;5788-5800.
6. Bache M., Pigorsch S., Dunst J., Wurl P., Meyer A., Bartel F., Schmidt H., Rath F.W., Taubert H. Loss of G2/M arrest correlates with radiosensitisation in 2 human sarcoma cell lines with mutant p53. Int. J. Cancer. 96:2001;110-117.
7. Binder A., Böhm L. Influence of irradiation and pentoxifylline on histone H3 phosphorylation in human tumour cell lines. Cell Prolif. 35:2002;37-47.
8. Binder A., Serafin A.M., Böhm L. Abrogation of the G2/M phase block enhances the cytotoxicity of Daunorubicin, Melphalan and cisplatin in p53 mutant human tumour cells. Radiat. Res. 154:2000;640-649.
9. Binder A., Theron T., Donninger H., Parker M.I., Böhm L. Radiosensitization and DNA repair inhibition by Pentoxifylline in NIH 3T3 p53 transfectants. Int. J. Radiat. Biol. 78:2002;991-1000.
10. Böhm L., Theron T., Binder A. Influence of Pentoxifylline A-802710 propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage. Biochim. Biophys. Acta. 1499:2000;1-10.
11. Busse P.M., Bose S.K., Jones R.W., Tolmach L.J. The action of caffeine on X-irradiated cells. II. Synergistic lethality. Radiat. Res. 71:1977;666-677.
12. Collinridge D.R., Rockwell S. Pentoxifylline improves the oxygenation and irradiation response of BA 1112 rat rhabdomyosarcomas and EMT 6 mouse mammary carcinomas. Int. J. Cancer, Radiat. Oncol. Invest. 90:2000;256-264.
13. De Frank J.S., Tang W., Powell S.N. p53 null cells are more sensitive to UV-light only in the presence of caffeine. Cancer Res. 56:1996;5365-5368.
14. Durante M., Furusawa Y., Majiama H., Kawata T., Gotoh E. Association between G2-phase block and repair of radiation induced chromosome fragments in human lymphocytes. Radiat. Res. 151:1999;670-676.
15. Eley K.W., Benedict S.H., Chung T.D.K., Kavanagh B.D., Broaddus W.C., Schmidt-Ullrich R.K.A., Lin P.S. The effects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic surgery irradiation. Int. J. Radiat., Oncol. Biol. Phys. 54:2002;542-556.
16. Ely H. Is Pentoxifylline the drug of the decade? J. Am. Acad. Dermatol. 30:1994;603-621.
17. Fan S., Smith M.L., Rivet D.J., Duba D., Zhan Q., Kohn K.W., Fornace A.J., O'Connor P.M.O. Disruption of p53 sensitizes breast cancer MCF-7 cells to cisplatin and Pentoxifylline. Cancer Res. 55:1995;1649-1654.
18. Fingert H.J., Pu A.T., Chen Z., Googe P.B., Alley M.C., Pardee A.B. In vivo and in vitro enhanced antitumour effect by Pentoxifylline in human cancer cells treated with Thiotepa. Cancer Res. 48:1988;4375-4381.
19. Gurley L.R., D'Anna J.A., Barham S.S., Deaven L.L., Tobey R.A. Histone phosphorylation and chromatin structure during mitosis in Chinese Hamster cells. Eur. J. Biochem. 84:1978;1-15.
20. Hall-Jackson C.A., Cross D.A., Morris N., Smyth K. ATR is a caffeine sensitive, DNA activated protein kinase with a substrate specificity distinct from DNA-PK. Oncogene. 18:1999;6707-6713.
21. Iliakis G., Nusse M. Effects of caffeine on x-irradiated synchronous, asynchronous and plateau phase mouse ascites cells: the importance of progression through the cell cycle for caffeine enhancement of cell killing. Int. J. Radiat. Biol. 43:1983;649-663.
22. Johnson K.W., Davis B.H., Smith K.A. c-AMP antagonizes interleukin2-promoted T-cell progression at a discrete point in early G1 phase. Proc. Natl. Acad. Sci. 85:1988;6072-6076.
23. Kastan M.B., Lim D.S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1:2000;179-186.
24. Kastan M.B., Onyekwere O., Sidranski D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
25. Kelleher D.K., Thews O., Vaupel P. Regional perfusion and oxygenation of tumours upon methylxanthine derivative administration. Int. J. Radiat. Oncol., Biol. Phys. 42:1998;861-864.
26. Kihlman, B.A., 1977. Caffeine and Chromosomes. Elsevier, Amsterdam.
27. Kishin F., Niahur Y., Kamada A., Kawakami Y. Pharmacological effects of hemoglobin-oxygen affinity in vitro in patients with chronic obstructive pulmonary disease. Adv. Exp. Med. Biol. 222:1988;341-347.
28. Kramer J.J., Swisslodei N.J. Pentoxifylline on membrane proteins phosphorylation in erythrocytes. Vasc. Med. 1:1983;159-174.
29. Lang H. Model for repair inhibition by caffeine. Studia Biophys. 50:1975;213-221.
30. Lavin M.F. Radiosensitivity and oxidative signalling in Ataxia telangiectasia: an update. Radiother. Oncol. 47:1998;113-123.
31. Lee I., Kim J.H., Levitt S.H., Song C.W. Increase in tumour response by Pentoxifylline alone or in combination with Nicotinamide. Int. J. Radiat. Oncol., Biol. Phys. 22:1992;425-429.
32. Lee I., Boucher Y., Demhartner T.J., Jam R.K. Changes in tumour blood flow oxygenation and interstitial fluid pressure induced by pentoxifylline. Br. J. Cancer. 69:1994;492-496.
33. Lee I., Biaglow J.E., Lee J., Cho M. Physiological mechanisms of radiation sensitisation by Pentoxifylline. Anticancer Res. 20:2000;4605-4610.
34. Lehmann A.R. Effect of caffeine on DNS synthesis in mammalian cells. Biophys. J. 12:1972;1316-1325.
35. Li Y., Weber-Johnson K., Sun L., Pashoud N., Mirimanoff R., Coucke P.A. Effect of Pentoxifylline on radiation induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells. Radiat. Res. 149:1998;338-342.
36. Li Y., Sun L., Weber-Johnson K., Pashoud N., Coucke P. Potentiation of cytotoxicity and radiosensitisation of 2-doxy-2′(fluoro-methylene) cytidine by pentoxifylline in vitro. Int. J. Cancer. 80:1999;155-160.
37. Link C.J., Evans M.K., Cook J.A., Muldoon R., Stevsner T., Bohr V.A. Caffeine inhibits gene specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cells. Carcinogenesis. 16:1995;1149-1155.
38. Link C.J., Orren D., Muldoon R., Cook J.A., Bohr V.A. Pentoxifylline inhibits gene specific repair of UV-induced damage in hamster cells. Radiat. Oncol. Invest. 4:1996;115-121.
39. Maurique R.V., Maurique V. Platelet resistance to prostacyclin enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline. Angiology. 38:1987;101-108.
40. Morrison C., Sonoda E., Takao N., Shinohara A., Yamato K.I., Takeda S. The controlling influence of ATM in homologous recombination repair of DNA damage. EMBO J. 19:2000;463-471.
41. Muller W.U., Bauch T., Wojcik A., Blocker W., Streffer C. Comet assay studies indicates that caffeine mediated increase in irradiation risk of embryos is due to inhibition of DNA repair. Mutagenesis. 11:1996;57-60.
42. Murray A.W. Creative blocks: cell cycle checkpoints and feedback controls. Nature. 359:1992;599-604.
43. Musk S.R.R. Reduction of radiation induced cell cycle blocks by caffeine does not necessarily lead to increased cell killing. Radiat. Res. 125:1991;262-266.
44. Musk S.R.R., Steel G.G. Override of the irradiation induced mitotic block in human tumour cells by methylxanthines and its relationship to the potentiation of cytotoxicity. Int. J. Radiat. Biol. 57:1990;1105-1112.
45. Natarajan A.T., Obe G., Dulout F.N. The effect of caffeine posttreatment on X-ray induced chromosome aberrations in human blood lymphocytes in vitro. Human Genet. 54:1980;183-189.
46. O'Connor P.M.O. Mammalian G1 and G2 phase checkpoints. Cancer Surg. 29:1997;151-182.
47. Pawlak A.L., Kolecki M., Ignatowicz R. Increased frequency of chromatid breaks in lymphocytes of heterozygotes of Ataxia telangiectasia after in vitro treatment with caffeine. Mutation Res. 230:1990;197-204.
48. Powell S.N., De Frank J.S., Connel P., Eogan M., Preffer F., Dombkowski D., Tang W., Friend S. Differential sensitivities of p53 (-) and p53 (+) cells to caffeine induced radiosensitisation and override of G2 delay. Cancer Res. 55:1995;1643-1648.
49. ® Maximum strength of caffeine. Bristol Myers Products, Hillside, NJ, USA.
50. Ribeiro J.C.C., Barnetson A.R., Jackson P.K., Links M., Russel P.J. Caffeine increased radiosensitivity is not dependent upon loss of G2/M arrest or apoptosis in bladder cancer cell lines. Int. J. Radiat. Biol. 75:1999;481-492.
51. Roos, W.P., Böhm, L., 2002. Unpublished observations.
52. Russel K.J., Wiens L.W., Demers G.W., Galloway D.A., Le T., Rice G.C., Bianco J.A., Singer J.W., Groudine M. Preferential radiosensitization of G1 checkpoint deficient cells by methylxanthines. Int. J. Radiat. Oncol., Biol. Phys. 36:1996;1099-1106.
53. Sarkaria J.N., Busby E.C., Tibbets R.S., Roos P., Taya Y., Karnitz L.M., Abraham R.T. Inhibition of ATM and ATR kinase activity by the radiosensitising agent caffeine. Cancer Res. 59:1999;4375-4382.
54. Schade U.F. The role of prostacyclins in the protective effect of pentoxifylline and other methylxanthine derivatives in endotoxin action on mice. Eicosanoids. 2:1989;183-185.
55. Selby C.P., Sancar A. Molecular mechanisms of DNA repair inhibition by caffeine. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3522-3525.
56. Serafin A.M., Binder A., Böhm L. Chemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogation. Urol. Res. 29:2001;221-227.
57. Smeets M.F., Mooren E.H., Abdel-Wahab A.H., Bartelink H., Begg A.C. Differential repair of radiation induced DNA-damage in cells of squamous cell carcinoma and the effect of caffeine and cysteamine on the induction and repair of DNA-double strand breaks. Radiat. Res. 140:1994;153-160.
58. Song C.W., Hasegawa T., Kwon H.C., Lyons J.C., Levitt S.A. Increase in tumour oxygenation and radiosensitivity caused by Pentoxifylline. Radiat. Res. 130:1992;205-210.
59. Song C.W., Makepeace C.M., Griffin R.J., Hasegawa T., Osborn J.L., Choi I.B., Nah B.S. Increase in tumour blood flow by Pentoxifylline. Int. J. Radiat. Oncol., Biol. Phys. 29:1994;433-437.
60. Theron T., Böhm L. Cyclin B1 expression in response to abrogation of the irradiation induced G2 block in HeLa cells. Cell Prolif. 31:1998;49-57.
61. Theron T., Böhm L. Influence of the G2 cell cycle block abrogator Pentoxifylline on the expression and subcellular location of cyclin B1 and p34 CDC-2 in HeLa cervical carcinoma cells. Cell Prolif. 33:2000;39-50.
62. Theron T., Binder A., Verheye-Dua F., Böhm L. The role of G2 block abrogation, DNA double strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines. Int. J. Radiat. Biol. 76:2000;1197-1208.
63. Tolmach L.J., Busse P.W. The action of caffeine on X-irradiated HeLa cells. IV. Progression delays and enhanced cell killing at high caffeine concentrations. Radiat. Res. 82:1980;374-392.
64. Vernimmen F., Verheye-Dua F., du Toit H., Böhm L. Effect of Pentoxifylline on irradiation damage and tumour growth. Strahlenther. Onkol. 170:1994;595-601.
65. Walters R.A., Gurley L.R., Tobey R.A. Effects of caffeine on radiation induced phenomena associated with cell cycle traverse of mammalian cells. Biophys. J. 14:1974;99-118.
66. Wang H., Wang X., Iliakis G., Wang Y. Caffeine could not effectively sensitize homologous recombination repair deficient cells to ionizing radiation induced cell killing. Radiat. Res. 159:2003a;420-425.
67. Wang X., Wang H., Iliakis G., Wang Y. Caffeine induced radiosensitisation is independent of non-homologous end joining of DNA double strand breaks. Radiat. Res. 159:2003b;426-432.
68. Ward A., Clissold S.P. Pentoxifylline: a review of the pharmacokinetic properties and therapeutic efficacy. Drugs. 34:1987;50-97.
69. Wong S.S., Holt P.J.A. General morphoea and primary biliary cirrhosis: a rare association and improvement with oxipentifylline. Clin. Exp. Dermatol. 17:1992;371-373.
70. Zabel P., Schonharting M.M., Wolter D.T. Oxipentifylline in endotoxemia. Lancet. 23:1989;1474-1477.
71. Zhou B.B.S., Elledge S.J. The DNA damage response: putting checkpoints into perspective. Nature. 408:2000;433-439.
72. Zywietz, F., Sagowski, C., Böhm, L., 2003. Pentoxifylline enhances tumour oxygenation and radiosensitivity in rat rhabdomyosarcomas during continuous hyperfractionated irradiation. Int. J. Radiat. Oncol., Biol. Phys., under revision.